Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...
The BrainSense Adaptive technology is an enhancement to Medtronic’s Percept DBS neurostimulators. The advancement ...
Bryan Johnson, the American entrepreneur renowned for his anti-ageing endeavours, has disclosed the details of his latest ...
The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...
Johnson & Johnson (JNJ) stock in focus as limited rollout of Varipulse heart device resumes after a safety review prompted by ...
The group representing medical device makers in Washington is coming out against the Trump administration’s firings of ...
A class action filed today says Kiwis have been deceived for about two decades through the use of phenylephrine in cold and ...
(RTTNews) - Johnson & Johnson (JNJ ... to placebo across all clinical and endoscopic measures consistent with the FDA-approved intravenous induction regimen in this population.
Mr Johnson said: ‘Psychedelics like ketamine, which have recently been FDA approved for limited use as therapeutics, are interesting because of their unique potential to improve mental wellness.
Also Read: Sanofi Genzyme Facility Draws FDA Criticism Over Alleged Quality ... Inc. (Janssen), a Johnson & Johnson company, to develop and commercialize the vaccine candidate.
Last week, the Trump administration ordered all federal agencies to lay off all probationary workers. As a result, hundreds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results